Video

Why One Woman Prefers the Term ‘Cancer Alumni’ After Treatment for Lymphoma

Author(s):

The term “survivor” is often used to describe people who have successfully completed their cancer treatments, but Sonia Su feels like it doesn’t quite capture the complexity of what it means to be in remission.

As a three-time “cancer alumni,” as she prefers to be called, Sonia Su recognizes the unforgiving nature of cancer.

In an interview with CURE®, Su, who was diagnosed with primary mediastinal large B-cell lymphoma, shared her perspective on why she feels that the term “survivor” does not offer a complete understanding of what it means to be in remission from cancer. She pointed out that receiving a cancer diagnosis will impact the rest of someone’s life, even after successfully completing treatment.

“We, as cancer survivors, essentially all took the ‘courses’ of cancer and graduated, and to use the word ‘survived’ essentially means that we’ll be okay from now on,” Su said. “And to be honest, we never know. The harsh reality is that cancer can come back at any point.”

Transcription

So, I don't think I really realized the potentially negative connotation of the word ‘survivor’ until I had actually presented this nonprofit idea to one of my professors, and he used the word ‘alumni,’ like cancer alumni.

And I thought that that was such a such a great term to use, because it's true. He was a cancer survivor as well. We, as cancer survivors, essentially all took the ‘courses’ of cancer and graduated, and to use the word ‘survived’ essentially means that we'll be okay from now on. And to be honest, we never know. The harsh reality is that cancer can come back at any point. And I mean for me, especially, I'm only two years out, and medically, I think, you know, five years is like the safe zone. So, I don't even know if I can call myself a survivor. And if anything, I know I'm an alumni. I did go through all of that. And you know, that was a crazy learning experience, and I learned a lot.

But I think just recognizing that a lot of us also have a lot of fear of recurrence constantly, especially for people who have had relapses (is important). And so, I think it's just more about being slightly more considerate about the reality of cancer. We’ve survived it, but even as survivors or alumni, we’ll have long term effects and you know, our lives are forever changed. So, it's not that we can exactly go back to normal. It's just (that) we're always going to be living with the effects of cancer.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.